RFA-NS-28-009: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
RFA-NS-28-009 is a National Institutes of Health notice on Grants.gov (forecasted) whose eligibility includes small businesses. Posted Sep 23, 2026; close date May 25, 2027. The eligibility text below is quoted from the notice; read the official notice before applying. Real federal grants never charge an application fee.
Eligibility
Eligible applicants must be clinical trial sites that participate in a phase 2/3 or phase 3 efficacy clinical trial (designed to provide pivotal data to establish substantial evidence of effectiveness in support of a marketing application) supported by a U.S. based small business concern that is the FDA-designated sponsor of a drug or biological product which is the subject of an IND under section 505(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)) to prevent, diagnose, mitigate, treat, or cure ALS. The definition of a small business concern can be found in section 3(a) of the Small Business Act (15 U.S.C. 632(a)).Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant types listed by Grants.gov: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); County governments; Public and State controlled institutions of higher education; City or township governments; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Small businesses; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Special district governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Agency, posted date, and close date
| Opportunity number | RFA-NS-28-009 |
|---|---|
| Agency | National Institutes of Health |
| Status on Grants.gov | forecasted |
| Posted | 2026-09-23 |
| Close date | 2027-05-25 |
| Notice type | forecast |
| Funding instrument | Cooperative Agreement |
| Category of funding activity | Health |
| Assistance listing (CFDA) | 93.853 |
Official Grants.gov notice
Open the official notice on Grants.gov ↗
Source: Grants.gov (search2 / fetchOpportunity API) (as of 2026-09-23). Figures can change; check the source.
Related notices
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-016 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-025 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-RM-27-007 · closes Nov 23, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-10-09
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Department of Health and Human Services
National Institutes of Health · PA-23-317 · closes Nov 24, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2023-11-24
Microplastics Research and Resource Coordination Center (U24 - Clinical Trial Not Allowed)
Department of Health and Human Services
National Institutes of Health · RFA-ES-27-003 · closes Dec 1, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2026-06-29
National Center for Construction Safety and Health Research and Translation (U54)
Department of Health and Human Services
Centers for Disease Control and Prevention - ERA · RFA-OH-24-001 · closes Dec 1, 2026
Source: Grants.gov (search2 / fetchOpportunity API) · as of 2023-09-13
Something wrong or outdated? Send a correction.